Haitham Alwali PhD Pharmacology Al Nahrain College of Pharmacy 2122018 Haitham Alwali 1 2122018 Haitham Alwali 2 A Drugs Used in AcidPeptic Diseases Ulceration and erosion of the lining of the upper portion ID: 930101
Download Presentation The PPT/PDF document "Drugs used in GIT disorders" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Drugs used in GIT disorders
Haitham AlwaliPh.D. PharmacologyAl-Nahrain College of Pharmacy
2/12/2018
Haitham Alwali
1
Slide22/12/2018
Haitham Alwali
2
Slide3A.
Drugs Used in Acid-Peptic DiseasesUlceration and erosion of the lining of the upper portion of the gastrointestinal tract are common problems that manifest as
gastroesophageal
reflux disease (GERD), gastric and
duodenal
peptic
ulcers
, and
stress-related mucosal injury.Drugs used in acid-peptic disease reduce intragastric acidity by manipulating systems controlling acid secretion, promote mucosal defense or, in the case of peptic ulcers, eradicate the bacterium Helicobacter pylori, which is detectable in over 80% of patients with duodenal ulcers.
2/12/2018
Haitham Alwali
3
Slide41.
Antacids: are weak bases that neutralize stomachacid by reacting with protons in the lumen of the gut and may also stimulate the protective functions of the gastric mucosa.
antacids reduce the recurrence rate of peptic ulcers.
Popular antacids include magnesium
hydroxide
(Mg[OH]2
) and
aluminum hydroxide
(Al[OH]3). Neither of these weak bases is significantly absorbed from the bowel. Magnesium hydroxide has a strong laxative effect, whereas aluminum hydroxide has a constipating action. These drugs are available as single-ingredient products and as combined preparations.2/12/2018Haitham Alwali
4
Slide5Calcium
carbonate and sodium bicarbonate are also weak bases, but they differ from aluminum
and magnesium hydroxides in being absorbed from the
gut. Because of their systemic effects
, calcium and bicarbonate
salts
are
less popular
as antacids.2. H2-receptor antagonists—Cimetidine and other H2 antagonists (ranitidine, famotidine, and nizatidine) inhibit stomach acid production, especially at night. They are effective in the treatment of GERD, peptic ulcer disease, and nonulcer dyspepsia and in the prevention of stress-related gastritis.
2/12/2018
Haitham Alwali
5
Slide63.
Proton pump inhibitors—Omeprazole and (esomeprazole, (dex)
lansoprazole, pantoprazole,
and rabeprazole) are lipophilic weak bases that diffuse into
the
parietal
cell canaliculi, where they
become
protonated and concentrated more than 1000-fold. There they undergo conversion to compounds that irreversibly inactivate the parietal cell H+/K+ ATPase, the transporter that is primarily responsible for producing stomach acid.2/12/2018Haitham Alwali6
Slide7Oral formulations of these drugs are
enteric coated to prevent acid inactivation in the stomach. After absorption in the intestine, they are rapidly metabolized in the liver, with
half-lives of 1–2 h. However, their durations of action are approximately
24 h, and they may require 3–4 d of treatment to achieve
their
full effectiveness
.
Proton pump inhibitors are
more effective than H2 antagonists for GERD and peptic ulcer and equally effective in the treatment of nonulcer dyspepsia and the prevention of stress-related mucosal bleeding. They are also useful in the treatment of Zollinger- Ellison syndrome. 2/12/2018Haitham Alwali
7
Slide8Adverse effects of proton pump inhibitors
occur infrequently and include diarrhea, abdominal pain,
and headache
. Chronic treatment with proton pump inhibitors may result
in
hypergastrinemia
.
Proton pump inhibitors may
decrease the oral
bioavailability of vitamin B12 and certain drugs that require acidity for their gastrointestinal absorption (eg, digoxin, ketoconazole).Patients taking proton pump inhibitors may have a small increase in the risk of respiratory and enteric infections.2/12/2018Haitham Alwali
8
Slide92/12/2018
Haitham Alwali9
Slide104.
Sucralfate— An aluminum sucrose sulfate, sucralfate is a small, poorly soluble molecule that polymerizes in the acid environment of
the stomach. The polymer binds to injured tissue and forms a protective coating over ulcer beds.
Sucralfate accelerates the healing of peptic ulcers and reduces the recurrence rate
.
5.
Misoprostol
—An analog of PGE1, misoprostol
increases mucosal
protection and inhibits acid secretion. It is effective in reducing the risk of ulcers in users of non steroidal anti-inflammatory drugs (NSAIDs).2/12/2018Haitham Alwali10
Slide116.
Antibiotics—Chronic infection with H pylori is present in most patients with recurrent non-NSAID-induced peptic ulcers.Eradication of this organism greatly reduces the rate of recurrence of ulcer in these patients. One regimen of choice consists
of a proton pump inhibitor plus a course of clarithromycin and
amoxicillin (or metronidazole in patients with penicillin allergy).
2/12/2018
Haitham Alwali
11
Slide12B.
Drugs That Promote Upper Gastrointestinal MotilityTheir ability to increase lower esophageal sphincter pressures also makes them useful for some patients with GERD
.In the enteric nervous system, dopamine inhibits cholinergic stimulation
of smooth muscle contraction. Metoclopramide
and
domperidone
are D2 dopamine receptor antagonists that
promote gastrointestinal
motility.When used chronically, metoclopramide can cause symptoms of parkinsonism, other extrapyramidal effects, and hyperprolactinemia. Because it does not cross the blood-brain barrier, domperidone is less likely to cause CNS toxicity.The macrolide antibiotic erythromycin promotes motility by stimulating motilin receptors.2/12/2018Haitham Alwali12
Slide13C.
Laxatives:Mechanism Examples1-Bulk-forming
Psyllium,
methylcellulose
2-
Stool-softening
glycerin
, mineral oil
3-
Osmotic Magnesium oxide, lactulose, 4-Stimulant Aloe, senna, cascara, castor oil, bisacodyl 5-Chloride channel Lubiprostone activator
2/12/2018Haitham Alwali
13
Slide14D. Antidiarrheal Agents
Diphenoxylate and loperamide, meperidine
analogs with very weak analgesic effects.
Diphenoxylate is formulated with
antimuscarinic
alkaloids
(
eg
, atropine) to reduce the likelihood of
abuse; loperamide is formulated alone. Kaolin, a naturally occurring hydrated magnesium aluminum silicate, is combined with pectin, an indigestible carbohydrate derived from apples ( absorbs bacterial toxins and fluid, resulting in decreased stool liquidity.these agents should not be used in patients with bloody diarrhea, high fever, or systemic toxicity because ofthe risk of worsening the underlying condition.2/12/2018Haitham Alwali
14
Slide15E.
Drugs Used for Irritable Bowel Syndrome(IBS) is associated with recurrent episodes of abdominal discomfort (pain, bloating, distention, or cramps)plus diarrhea or constipation (or both).
The pharmacologic strategy includes
antidiarrheal agents OR laxatives
; and
for the treatment of abdominal
pain, low
doses of tricyclic antidepressants
dicyclomine
and hyoscyamine are used as antispasmodics to relieve abdominal painAlosetron, a potent 5-HT3 antagonist, is approved for treatment of women with severe IBS with diarrhea.Lubiprostone, a laxative that activates the type 2 chloride channels in the small intestine.2/12/2018Haitham Alwali15
Slide16F. Drugs With Antiemetic
ActionsIn addition to metoclopramide and other D2 dopamine receptor antagonists, useful antiemetics
are drugs with H1 histamine blocking activity (diphenhydramine), and several phenothiazines
; antimuscarinic drugs such as
scopolamine
; the
corticosteroid
dexamethasone
; and the cannabinoid receptor agonists dronabinol.The 5-HT3 antagonists ondansetron, granisetron, dolasetron are useful in preventing nausea and vomiting after general anesthesia and in patients receiving cancer chemotherapy.Aprepitant, a newer antiemetic, is an antagonist of the neurokinin 1 (NK1) receptor, a receptor in the CNS that is activated by substance P and other tachykinins.
2/12/2018
Haitham Alwali
16
Slide17G.
Drugs Used in Inflammatory Bowel Disease (IBD)Aminosalicylates—Drugs containing 5
aminosalicylic acid (5-ASA) are used as topical therapy for IBD.
The precise mechanism of 5-ASA action is uncertain but may involve
inhibiting the
synthesis of prostaglandins and inflammatory
leukotrienes
.
Balsalazide
and sulfasalazine (a combination of 5-ASA and sulfapyridine) has a higher incidence of adverse effects (sulfapyridine moiety) include gastrointestinal upset, headaches, arthralgias, bone marrow suppression, andsevere hypersensitivity reactions2. Other agents: include
antibiotics, glucocorticoids
(budesonide),
immunosuppressive antimetabolites
(
eg
, azathioprine, methotrexate)
antitumor necrosis
factor
[TNF] drugs (
eg
, infliximab,
adalimumab
).
2/12/2018
Haitham Alwali
17
Slide18H. Pancreatic Enzyme
Replacements:Steatorrhea, a condition of decreased fat absorption together with an increase in stool fat excretion, results from
inadequate pancreatic secretion of lipase
.The abnormality of fat absorption can be significantly
relieved by oral administration of pancreatic
lipase (
pancrelipase
or
pancreatin) obtained from pigs.Pancreatic lipase is inactivated at a pH lower than 4.0; the enzyme should be taken as enteric-coated capsules.I. Drugs That Inhibit the Formation of GallstonesThe formation of cholesterol gallstones can be inhibited by the bile acid derivative ursodiol, which decreases the cholesterol content of bile by decreasing hepatic cholesterol secretion.2/12/2018Haitham Alwali
18